After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
AUPH belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Aurinia Pharmaceuticals Inc is $1.12B. A total of 1.15 million shares were traded on the day, compared to an average of 1.47M shares.
In the most recent transaction, Keenan Greg sold 8,305 shares of AUPH for 8.23 per share on Mar 07 ’25. After the transaction, the Chief Medical Officer now owns 153,484 company shares. In a previous transaction on Mar 03 ’25, Greenleaf Peter sold 195,593 shares at 8.00 per share. AUPH shares that Chief Executive Officer owns now total 1,953,892.
Among the insiders who sold shares, Greenleaf Peter disposed of 164,947 shares on Mar 04 ’25 at a per-share price of $7.92. This resulted in the Chief Executive Officer holding 1,788,945 shares of AUPH after the transaction. In another insider transaction, Keenan Greg sold 12,239 shares at $8.00 per share on Mar 03 ’25. Company shares held by the Chief Medical Officer now total 161,789.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, AUPH has a high of $10.67 and a low of $4.71.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AUPH’s latest balance sheet shows that the firm has $466.08M in Cash & Short Term Investments as of fiscal 2021. There were $8.74M in debt and $40.65M in liabilities at the time. Its Book Value Per Share was $2.68, while its Total Shareholder’s Equity was $479.09M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AUPH is Buy with a score of 4.43.
